[Federal Register Volume 68, Number 26 (Friday, February 7, 2003)]
[Notices]
[Page 6514]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-3050]



[[Page 6514]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 28, 2002, and published in the Federal 
Register on August 7, 2002, (67 FR 51294), Johnson Matthey, Inc., 
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New 
Jersey 08066, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................  I
Difenoxin (9168)............................  I
Propiram (9649).............................  I
Amphetamine (1100)..........................  II
Methylphenidate (1724)......................  II
Codeine (9050)..............................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Hydrocodone (9193)..........................  II
Meperidine (9230)...........................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
Alfentanil (9737)...........................  II
Sufentanil (9740)...........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances in 
bulk to supply final dosage form manufacturers.
    DEA has considered the factors in Title 21, United States Code, 
section 823(a) and determined that the registration of Johnson Matthey, 
Inc. to manufacture the listed controlled substances is consistent with 
the public interest at this time. DEA has investigated Johnson Matthey, 
Inc. on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: January 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-3050 Filed 2-6-03; 8:45 am]
BILLING CODE 4410-09-M